ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balbi, B
Right arrow Articles by Fabiano, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balbi, B
Right arrow Articles by Fabiano, F
Eur Respir J 1997; 10: 846-850
Copyright © ERS Journals Ltd 1997


Clinical Trial

Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis

B Balbi, C Bason, E Balleari, F Fiasella, A Pesci, R Ghio, and F Fabiano

Although inflammatory changes are found throughout the airways of patients with chronic bronchitis, the mechanisms of the pathogenesis of chronic bronchitis are still unclear. The aim of this study was to investigate airways inflammation in patients with and without an exacerbation of bronchitis. Thirteen chronic bronchitic patients and nine normal subjects were studied. Eight of the patients were studied under baseline conditions (B), and five during an exacerbation of bronchitis (E). Bronchoscopy and bronchoalveolar lavage (BAL) with cytological analysis were performed, and the levels of granulocyte/macrophage colony-stimulating factor (GM-CSF) were determined in sera and in BAL supernatants by a solid phase enzyme immunoassay. Compared with patients under baseline conditions, chronic bronchitic patients with an exacerbation had increased numbers of BAL neutrophils (10+/-3 and 83+/-18x10(3) cells x mL(-1), respectively; p<0.0001) and of BAL eosinophils (1.9+/-0.5 and 6.7/-1.9x10(3) cells x mL(-1), respectively; p=0.014). Patients with chronic bronchitis, as a whole, had significantly increased levels of BAL GM-CSF compared to control subjects (36+/-5 and 19+/-4 pg x mL(-1), respectively; p=0.035), and similar levels of serum GM-CSF. Serum levels of GM-CSF were markedly increased in chronic bronchitic patients with an exacerbation, as compared with patients under baseline conditions (1.4+/-0.4 and 13+/-1 pg x mL(-1), respectively; p <0.0001). BAL levels of GM-CSF were also increased in chronic bronchitic patients with an exacerbation (25+/-5 and 54+/-8 pg x mL(-1), respectively; p=0.009). During exacerbations of chronic bronchitis there are changes in the cell populations in bronchoalveolar lavage of patients consistent with a recruitment of polymorphonuclear leucocytes in the airway lumen. The increased levels of granulocyte/macrophage colony-stimulating factor might suggest a role for this cytokine in the inflammatory processes of chronic bronchitis.


This article has been cited by other articles:


Home page
Eur Respir JHome page
J-Q. He, K. Shumansky, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford
Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD
Eur. Respir. J., July 1, 2008; 32(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Anzueto, S. Sethi, and F. J. Martinez
Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, October 1, 2007; 4(7): 554 - 564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. C. Newcomb, U. S. Sajjan, D. R. Nagarkar, A. M. Goldsmith, J. K. Bentley, and M. B. Hershenson
Cooperative effects of rhinovirus and TNF-{alpha} on airway epithelial cell chemokine expression
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1021 - L1028.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
E.-M. Krinner, J. Hepp, P. Hoffmann, S. Bruckmaier, L. Petersen, S. Petsch, L. Parr, I. Schuster, S. Mangold, G. Lorenczewski, et al.
A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration
Protein Eng. Des. Sel., October 1, 2006; 19(10): 461 - 470.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Slevogt, B. Schmeck, C. Jonatat, J. Zahlten, W. Beermann, V. van Laak, B. Opitz, S. Dietel, P. D. N'Guessan, S. Hippenstiel, et al.
Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-{kappa}B activation and histone deacetylase activity reduction
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L818 - L826.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
E Sapey and R A Stockley
COPD exacerbations {middle dot} 2: Aetiology.
Thorax, March 1, 2006; 61(3): 250 - 258.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. Mallia and S. L. Johnston
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS, November 1, 2005; 2(4): 361 - 366.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Farkas, M.-C. Hahn, M. Schmoczer, N. Jentsch, K. Kratzel, M. Pfeifer, and C. Schulz
Expression of CXC Chemokine Receptors 1 and 2 in Human Bronchial Epithelial Cells
Chest, November 1, 2005; 128(5): 3724 - 3734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute
Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. L. Johnston
Overview of Virus-induced Airway Disease
Proceedings of the ATS, August 1, 2005; 2(2): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Linden, M. Laan, and G. P. Anderson
Neutrophils, interleukin-17A and lung disease
Eur. Respir. J., January 1, 2005; 25(1): 159 - 172.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Panzner, J.-J. Lafitte, A. Tsicopoulos, Q. Hamid, and M. K. Tulic
Marked Up-regulation of T Lymphocytes and Expression of Interleukin-9 in Bronchial Biopsies From Patients With Chronic Bronchitis With Obstruction
Chest, November 1, 2003; 124(5): 1909 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. Qiu, J. Zhu, V. Bandi, R. L. Atmar, K. Hattotuwa, K. K. Guntupalli, and P. K. Jeffery
Biopsy Neutrophilia, Neutrophil Chemokine and Receptor Gene Expression in Severe Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 968 - 975.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Profita, G Chiappara, F Mirabella, R Di Giorgi, L Chimenti, G Costanzo, L Riccobono, V Bellia, J Bousquet, and A M Vignola
Effect of cilomilast (Ariflo) on TNF-{alpha}, IL-8, and GM-CSF release by airway cells of patients with COPD
Thorax, July 1, 2003; 58(7): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Laan, O. Prause, M. Miyamoto, M. Sjostrand, A.M. Hytonen, T. Kaneko, J. Lotvall, and A. Linden
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-{alpha}
Eur. Respir. J., March 1, 2003; 21(3): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A J White, S Gompertz, and R A Stockley
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
Thorax, January 1, 2003; 58(1): 73 - 80.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. V. Culpitt, D. F. Rogers, P. Shah, C. De Matos, R. E. K. Russell, L. E. Donnelly, and P. J. Barnes
Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 24 - 31.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Gompertz, C. O'Brien, D.L. Bayley, S.L. Hill, and R.A. Stockley
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Eur. Respir. J., June 1, 2001; 17(6): 1112 - 1119.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A. Hill, S. Gompertz, and R. Stockley
Factors influencing airway inflammation in chronic obstructive pulmonary disease
Thorax, November 1, 2000; 55(11): 970 - 977.
[Full Text]


Home page
ChestHome page
T. F. Murphy, S. Sethi, and M. S. Niederman
The Role of Bacteria in Exacerbations of COPD : A Constructive View
Chest, July 1, 2000; 118(1): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Balbi, M. Majori, S. Bertacco, G. Convertino, A. Cuomo, C. F. Donner, and A. Pesci
Inhaled Corticosteroids in Stable COPD Patients : Do They Have Effects on Cells and Molecular Mediators of Airway Inflammation?
Chest, June 1, 2000; 117(6): 1633 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Nagata, J. B. Sedgwick, H. Kita, and W. W. Busse
Granulocyte Macrophage Colony-stimulating Factor Augments ICAM-1 and VCAM-1 Activation of Eosinophil Function
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 158 - 166.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.